Cargando…

Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study

BACKGROUND: Increased serum neopterin had been described in older age two decades ago. Neopterin is a biomarker of systemic adaptive immune activation that could be potentially implicated in metabolic syndrome (MetS). Measurements of waist circumference, triglycerides, high-density lipoprotein chole...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Shu-Chun, Boeing, Heiner, Vollset, Stein Emil, Midttun, Øivind, Ueland, Per Magne, Bueno-de-Mesquita, Bas, Lajous, Martin, Fagherazzi, Guy, Boutron-Ruault, Marie-Christine, Kaaks, Rudolf, Küehn, Tilman, Pischon, Tobias, Drogan, Dagmar, Tjønneland, Anne, Overvad, Kim, Quirós, J Ramón, Agudo, Antonio, Molina-Montes, Esther, Dorronsoro, Miren, Huerta, José María, Barricarte, Aurelio, Khaw, Kay-Tee, Wareham, Nicholas J., Travis, Ruth C., Trichopoulou, Antonia, Lagiou, Pagona, Trichopoulos, Dimitrios, Masala, Giovanna, Agnoli, Claudia, Tumino, Rosario, Mattiello, Amalia, Peeters, Petra H, Weiderpass, Elisabete, Palmqvist, Richard, Ljuslinder, Ingrid, Gunter, Marc, Lu, Yunxia, Cross, Amanda J., Riboli, Elio, Vineis, Paolo, Aleksandrova, Krasimira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766742/
https://www.ncbi.nlm.nih.gov/pubmed/26918023
http://dx.doi.org/10.1186/s12979-016-0059-y
_version_ 1782417722114572288
author Chuang, Shu-Chun
Boeing, Heiner
Vollset, Stein Emil
Midttun, Øivind
Ueland, Per Magne
Bueno-de-Mesquita, Bas
Lajous, Martin
Fagherazzi, Guy
Boutron-Ruault, Marie-Christine
Kaaks, Rudolf
Küehn, Tilman
Pischon, Tobias
Drogan, Dagmar
Tjønneland, Anne
Overvad, Kim
Quirós, J Ramón
Agudo, Antonio
Molina-Montes, Esther
Dorronsoro, Miren
Huerta, José María
Barricarte, Aurelio
Khaw, Kay-Tee
Wareham, Nicholas J.
Travis, Ruth C.
Trichopoulou, Antonia
Lagiou, Pagona
Trichopoulos, Dimitrios
Masala, Giovanna
Agnoli, Claudia
Tumino, Rosario
Mattiello, Amalia
Peeters, Petra H
Weiderpass, Elisabete
Palmqvist, Richard
Ljuslinder, Ingrid
Gunter, Marc
Lu, Yunxia
Cross, Amanda J.
Riboli, Elio
Vineis, Paolo
Aleksandrova, Krasimira
author_facet Chuang, Shu-Chun
Boeing, Heiner
Vollset, Stein Emil
Midttun, Øivind
Ueland, Per Magne
Bueno-de-Mesquita, Bas
Lajous, Martin
Fagherazzi, Guy
Boutron-Ruault, Marie-Christine
Kaaks, Rudolf
Küehn, Tilman
Pischon, Tobias
Drogan, Dagmar
Tjønneland, Anne
Overvad, Kim
Quirós, J Ramón
Agudo, Antonio
Molina-Montes, Esther
Dorronsoro, Miren
Huerta, José María
Barricarte, Aurelio
Khaw, Kay-Tee
Wareham, Nicholas J.
Travis, Ruth C.
Trichopoulou, Antonia
Lagiou, Pagona
Trichopoulos, Dimitrios
Masala, Giovanna
Agnoli, Claudia
Tumino, Rosario
Mattiello, Amalia
Peeters, Petra H
Weiderpass, Elisabete
Palmqvist, Richard
Ljuslinder, Ingrid
Gunter, Marc
Lu, Yunxia
Cross, Amanda J.
Riboli, Elio
Vineis, Paolo
Aleksandrova, Krasimira
author_sort Chuang, Shu-Chun
collection PubMed
description BACKGROUND: Increased serum neopterin had been described in older age two decades ago. Neopterin is a biomarker of systemic adaptive immune activation that could be potentially implicated in metabolic syndrome (MetS). Measurements of waist circumference, triglycerides, high-density lipoprotein cholesterol (HDLC), systolic and diastolic blood pressure, glycated hemoglobin as components of MetS definition, and plasma total neopterin concentrations were performed in 594 participants recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC). RESULTS: Higher total neopterin concentrations were associated with reduced HDLC (9.7 %, p < 0.01 for men and 9.2 %, p < 0.01 for women), whereas no association was observed with the rest of the MetS components as well as with MetS overall (per 10 nmol/L: OR = 1.42, 95 % CI = 0.85-2.39 for men and OR = 1.38, 95 % CI = 0.79-2.43). CONCLUSIONS: These data suggest that high total neopterin concentrations are cross-sectionally associated with reduced HDLC, but not with overall MetS.
format Online
Article
Text
id pubmed-4766742
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47667422016-02-26 Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study Chuang, Shu-Chun Boeing, Heiner Vollset, Stein Emil Midttun, Øivind Ueland, Per Magne Bueno-de-Mesquita, Bas Lajous, Martin Fagherazzi, Guy Boutron-Ruault, Marie-Christine Kaaks, Rudolf Küehn, Tilman Pischon, Tobias Drogan, Dagmar Tjønneland, Anne Overvad, Kim Quirós, J Ramón Agudo, Antonio Molina-Montes, Esther Dorronsoro, Miren Huerta, José María Barricarte, Aurelio Khaw, Kay-Tee Wareham, Nicholas J. Travis, Ruth C. Trichopoulou, Antonia Lagiou, Pagona Trichopoulos, Dimitrios Masala, Giovanna Agnoli, Claudia Tumino, Rosario Mattiello, Amalia Peeters, Petra H Weiderpass, Elisabete Palmqvist, Richard Ljuslinder, Ingrid Gunter, Marc Lu, Yunxia Cross, Amanda J. Riboli, Elio Vineis, Paolo Aleksandrova, Krasimira Immun Ageing Research BACKGROUND: Increased serum neopterin had been described in older age two decades ago. Neopterin is a biomarker of systemic adaptive immune activation that could be potentially implicated in metabolic syndrome (MetS). Measurements of waist circumference, triglycerides, high-density lipoprotein cholesterol (HDLC), systolic and diastolic blood pressure, glycated hemoglobin as components of MetS definition, and plasma total neopterin concentrations were performed in 594 participants recruited in the European Prospective Investigation into Cancer and Nutrition (EPIC). RESULTS: Higher total neopterin concentrations were associated with reduced HDLC (9.7 %, p < 0.01 for men and 9.2 %, p < 0.01 for women), whereas no association was observed with the rest of the MetS components as well as with MetS overall (per 10 nmol/L: OR = 1.42, 95 % CI = 0.85-2.39 for men and OR = 1.38, 95 % CI = 0.79-2.43). CONCLUSIONS: These data suggest that high total neopterin concentrations are cross-sectionally associated with reduced HDLC, but not with overall MetS. BioMed Central 2016-02-25 /pmc/articles/PMC4766742/ /pubmed/26918023 http://dx.doi.org/10.1186/s12979-016-0059-y Text en © Chuang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chuang, Shu-Chun
Boeing, Heiner
Vollset, Stein Emil
Midttun, Øivind
Ueland, Per Magne
Bueno-de-Mesquita, Bas
Lajous, Martin
Fagherazzi, Guy
Boutron-Ruault, Marie-Christine
Kaaks, Rudolf
Küehn, Tilman
Pischon, Tobias
Drogan, Dagmar
Tjønneland, Anne
Overvad, Kim
Quirós, J Ramón
Agudo, Antonio
Molina-Montes, Esther
Dorronsoro, Miren
Huerta, José María
Barricarte, Aurelio
Khaw, Kay-Tee
Wareham, Nicholas J.
Travis, Ruth C.
Trichopoulou, Antonia
Lagiou, Pagona
Trichopoulos, Dimitrios
Masala, Giovanna
Agnoli, Claudia
Tumino, Rosario
Mattiello, Amalia
Peeters, Petra H
Weiderpass, Elisabete
Palmqvist, Richard
Ljuslinder, Ingrid
Gunter, Marc
Lu, Yunxia
Cross, Amanda J.
Riboli, Elio
Vineis, Paolo
Aleksandrova, Krasimira
Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title_full Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title_fullStr Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title_full_unstemmed Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title_short Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
title_sort cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766742/
https://www.ncbi.nlm.nih.gov/pubmed/26918023
http://dx.doi.org/10.1186/s12979-016-0059-y
work_keys_str_mv AT chuangshuchun cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT boeingheiner cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT vollsetsteinemil cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT midttunøivind cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT uelandpermagne cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT buenodemesquitabas cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT lajousmartin cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT fagherazziguy cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT boutronruaultmariechristine cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT kaaksrudolf cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT kuehntilman cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT pischontobias cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT drogandagmar cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT tjønnelandanne cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT overvadkim cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT quirosjramon cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT agudoantonio cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT molinamontesesther cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT dorronsoromiren cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT huertajosemaria cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT barricarteaurelio cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT khawkaytee cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT warehamnicholasj cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT travisruthc cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT trichopoulouantonia cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT lagioupagona cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT trichopoulosdimitrios cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT masalagiovanna cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT agnoliclaudia cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT tuminorosario cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT mattielloamalia cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT peeterspetrah cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT weiderpasselisabete cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT palmqvistrichard cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT ljuslinderingrid cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT guntermarc cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT luyunxia cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT crossamandaj cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT ribolielio cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT vineispaolo cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy
AT aleksandrovakrasimira cellularimmuneactivitybiomarkerneopterinisassociatedhyperlipidemiaresultsfromalargepopulationbasedstudy